Request Deal Involvement

Bristol Myers Squibb completed the acquisition of RayzeBio for $4.1bn.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Cooley

legal advisors

Cooley

Centerview Partners

financial advisors

Centerview Partners

Wilson Sonsini Goodrich & Rosati

legal advisors

Wilson Sonsini Goodrich & Rosati

Goodwin Procter

legal advisors to financial advisors

Goodwin Procter

Joele Frank

pr advisors

Joele Frank

Bank of America

financial advisors

Bank of America

Covington & Burling

legal advisors

Covington & Burling

or

Principals

RAYZEBIO

target

RAYZEBIO

BRISTOL MYERS SQUIBB COMPANY

bidder

BRISTOL MYERS SQUIBB COMPANY

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Bristol Myers Squibb completed the acquisition of RayzeBio for $4.1bn.